Correction: High-risk neuroblastoma stage 4 (NBS4): multi-target inhibitors for c-Src kinases (Csk) and retinoic acid (RA) signalling pathways

Amgad Gerges; Una Canning

doi:10.37349/eds.2026.1008142

Open Access

Correction

Correction: High-risk neuroblastoma stage 4 (NBS4): multi-target inhibitors for c-Src kinases (Csk) and retinoic acid (RA) signalling pathways

Affiliation:

¹Bioscience Department, School of Human Sciences, London Metropolitan University, N7 8DB London, United Kingdom

Email: a.gerges@londonmet.ac.uk

ORCID: https://orcid.org/0000-0002-1979-9129

Amgad Gerges ^1*

Affiliation:

²Independent Scholar, SE4 1JT London, United Kingdom

ORCID: https://orcid.org/0000-0002-0091-9776

Una Canning ²

Explor Drug Sci. 2026;4:1008142 DOI: https://doi.org/10.37349/eds.2026.1008142

Received: Accepted: Published: January 09, 2026

Correction to “High-risk neuroblastoma stage 4 (NBS4): multi-target inhibitors for c-Src kinases (Csk) and retinoic acid (RA) signalling pathways” by Gerges A and Canning U. Explor Drug Sci. 2025;3:1008109. DOI: 10.37349/eds.2025.1008109

The authors have recognized an error in the published paper:

In Figure 12, the cluster label shown within the synthesis route box was incorrectly presented as “Cluster 4, 1 of 25”. The correct label should read “Cluster 4, 1 of 1”. The corrected version of the figure is provided below.

Display full size

Figure 12. Synthesis of cluster 4, 1 of 1, c-Src inhibitor.

This correction does not affect the scientific content, interpretation of the results, or the conclusions of the paper. The authors apologize for any inconvenience caused to the readers by this error.

The original uncorrected PDF can be accessed from https://www.explorationpub.com/uploads/1008109_1st.pdf

Copyright: © The Author(s) 2026. This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.